Search results
Showing 151 to 200 of 2065 results for work
This guideline covers how to increase uptake of the free flu vaccination among people who are eligible. It describes ways to increase awareness and how to use all opportunities in primary and secondary care to identify people who should be encouraged to have the vaccination.
Home What NICE does Our research work HTA Lab...
This quality standard covers diagnosis of pancreatic cancer and management of pancreatic ductal adenocarcinoma in adults aged over 18. This quality standard describes high-quality care in priority areas for improvement. It does not cover national initiatives, such as cancer screening or audit.
View quality statements for QS177Show all sections
Sections for QS177
- Quality statements
- Quality statement 1: Specialist pancreatic cancer multidisciplinary teams
- Quality statement 2: Staging using FDG-PET/CT
- Quality statement 3: Resectional surgery
- Quality statement 4: Pancreatic enzyme replacement therapy
- Quality statement 5 (placeholder): Effective interventions to address psychological needs
- Update information
- About this quality standard
Getting involved as a voluntary and community sector organisation
Getting involved with NICE as a voluntary and community sector organisation
Involving you in the development of NICE guidance.
An outline of the roles and responsibilities of the National Institute for Health and Care Excellence.
This quality standard covers testing, diagnosing and managing hepatitis B in adults, young people and children (from birth). It describes high-quality care in priority areas for improvement.
View quality statements for QS65Show all sections
Sections for QS65
- Quality statements
- Quality statement 1: Testing and vaccination for hepatitis B
- Quality statement 2: Referral for specialist care
- Quality statement 3: Referral to and assessment by specialist care for pregnant women who are identified as hepatitis B surface antigen-positive at antenatal screening
- Quality statement 4: Complete course of neonatal hepatitis B vaccination and blood testing at 12 months
- Quality statement 5: Personalised care plan
- Quality statement 6: Monitoring people with chronic hepatitis B infection who do not meet the criteria for antiviral treatment
- Quality statement 7: 6-monthly surveillance testing for hepatocellular carcinoma in adults with chronic hepatitis B infection who have significant liver fibrosis or cirrhosis
Health Technology Assessment Innovation Laboratory (HTA Lab)
NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers...
We want you to help NICE to develop our guidance for NHS and care services.
Human alpha1-proteinase inhibitor for treating emphysema (terminated appraisal) (TA965)
NICE is unable to make a recommendation on human alpa1-proteinase inhibitor (Respreeza) for treating emphysema in adults. CSL Behring UK has confirmed that it does not intend to launch the product in England and Wales. The reasons for this decision are primarily related to the company’s inability to offer the product at a price to meet the current threshold of cost effectiveness.
Show all sections
Sections for TA965
This guideline covers promoting physical activity for children and young people aged under 18 at home, preschool, school and in the community. It includes raising awareness of the benefits of physical activity, listening to what children and young people want, planning and providing spaces and facilities, and helping families build physical activity into their daily lives.
This quality standard covers providing and organising services for people with sarcoma. It includes pathways for referral and diagnosis, treatment and support for adults, young people and children with sarcoma. It describes high-quality care in priority areas for improvement.
View quality statements for QS78Show all sections
Sections for QS78
- Quality statements
- Quality statement 1: Diagnostic pathways
- Quality statement 2: Multidisciplinary teams for sarcoma
- Quality statement 3: Publishing information about areas of expertise
- Quality statement 4: Retroperitoneal sarcoma
- Quality statement 5: Surgical skills
- Quality statement 6: Key workers
- Update information
This guideline covers good practice for developing, authorising, using and updating patient group directions. It also offers advice on deciding whether a patient group direction is needed.
View recommendations for MPG2Show all sections
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers...
This quality standard covers ways to reduce suicide and help people bereaved or affected by suicide. It describes high-quality care in priority areas for improvement.
View quality statements for QS189Show all sections
Sections for QS189
- Quality statements
- Quality statement 1: Multi-agency suicide prevention partnerships
- Quality statement 2: Reducing access to methods of suicide
- Quality statement 3: Media reporting
- Quality statement 4: Involving family, carers or friends
- Quality statement 5: Supporting people bereaved or affected by a suspected suicide
- Update information
- About this quality standard
In development Reference number: GID-TA10575 Expected publication date: 22 April 2026
Join NICE's people and communities network
This quality standard covers services for domestic violence and abuse in adults and young people (aged 16 and over). It includes identifying and supporting people experiencing domestic violence or abuse, as well as support for those who carry it out. It also covers children and young people (under 16) who are affected by domestic violence or abuse that is not carried out against them. It describes high-quality care in priority areas for improvement.
View quality statements for QS116Show all sections
Sections for QS116
- Quality statements
- Quality statement 1: Asking about domestic violence and abuse
- Quality statement 2: Response to domestic violence and abuse
- Quality statement 3: Referral to specialist support services for people experiencing domestic violence or abuse
- Quality statement 4: Referral to specialist services for people perpetrating domestic violence or abuse
- About this quality standard
This quality standard covers increasing the uptake of flu vaccination among people who are eligible. It describes high-quality care in priority areas for improvement.
How voluntary and community sector organisations can help us develop guidance
How voluntary and community sector (VCS) organisations can help NICE develop guidance
Safe staffing for nursing in adult inpatient wards in acute hospitals (SG1)
This guideline covers organisational and managerial approaches to safe nurse staffing of inpatient wards for people aged 18 and over in acute hospitals. It aims to ensure that patients receive the nursing care they need, regardless of the ward to which they are allocated, the time of the day, or the day of the week.
In development Reference number: GID-QS10188 Expected publication date: TBC
Awaiting development Reference number: GID-QS10106 Expected publication date: TBC
Awaiting development Reference number: GID-QS10099 Expected publication date: TBC
Awaiting development Reference number: GID-QS10107 Expected publication date: TBC
Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer (TA1021)
Evidence-based recommendations on crizotinib (Xalkori) for treating ROS1-positive advanced non-small-cell lung cancer in adults.
Ublituximab for treating relapsing multiple sclerosis (TA1025)
Evidence-based recommendations on ublituximab (Briumvi) for treating relapsing multiple sclerosis in adults.
In development Reference number: GID-QS10189 Expected publication date: 07 January 2027
Awaiting development Reference number: GID-QS10036 Expected publication date: TBC
Awaiting development Reference number: GID-QS10038 Expected publication date: TBC
Awaiting development Reference number: GID-QS10085 Expected publication date: TBC
Awaiting development Reference number: GID-QS10086 Expected publication date: TBC
Awaiting development Reference number: GID-QS10088 Expected publication date: TBC
Awaiting development Reference number: GID-QS10091 Expected publication date: TBC
Awaiting development Reference number: GID-QS10093 Expected publication date: TBC
Shared decision-making: practical guidance for health and social care professionals
Awaiting development Reference number: GID-QS10097 Expected publication date: TBC
Awaiting development Reference number: GID-QS10100 Expected publication date: TBC
Awaiting development Reference number: GID-QS10101 Expected publication date: TBC
Awaiting development Reference number: GID-QS10103 Expected publication date: TBC
Vulnerable populations: strategies for tackling inequalities
Awaiting development Reference number: GID-QS10124 Expected publication date: TBC
Awaiting development Reference number: GID-QS10129 Expected publication date: TBC
Awaiting development Reference number: GID-QS10130 Expected publication date: TBC
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social care
Awaiting development Reference number: GID-QS10144 Expected publication date: TBC
Advocacy services for adults with health and social care needs
Awaiting development Reference number: GID-QS10145 Expected publication date: TBC
Awaiting development Reference number: GID-QS10146 Expected publication date: TBC
Awaiting development Reference number: GID-QS10147 Expected publication date: TBC
Awaiting development Reference number: GID-QS10149 Expected publication date: TBC
Awaiting development Reference number: GID-QS10109 Expected publication date: TBC
Awaiting development Reference number: GID-QS10105 Expected publication date: TBC